Literature DB >> 26204180

Trypanosoma cruzi DTU TcII presents higher blood parasitism than DTU TcI in an experimental model of mixed infection.

Helioswilton Sales-Campos, Henrique Borges Kappel, Cristiane Pontes Andrade, Tiago Pereira Lima, Alessandra de Castilho, Luis Eduardo Ramirez Giraldo, Eliane Lages-Silva.   

Abstract

Trypanosoma cruzi (Tc), the causative agent of Chagas disease, affects millions of people worldwide. One of the major characteristics of T. cruzi is related to its heterogeneity due to the variability of its biological properties, parasite growth rates, infectivity, tissue tropism, morbidity and virulence among different isolates observed during experimental or human infection. Moreover, presence of mixed infections in the same host in endemic areas is a matter of study due to its impact on clinical manifestations and disease progression. In this study, we evaluated the biological behavior of two Tc I strains AQ1-7 (AQ) and MUTUM (MT) and one Tc II strain (JG) during the acute phase of infection, in unique and mixed infections. A patent blood parasitism was detected only in mice inoculated with JG strain . In addition blood parasitism parameters (peak and average blood parasitism) were positively associated when JG and AQ strains were combined. In contrast, a negative association was observed in the JG+MUTUM group. The predominance of TcII strain over TcI strains was highlighted using the LSSP-PCR technique, which was performed in samples from hemoculture. Thus, this study showed important biological differences between different T. cruzi strains and discrete typing units (DTUs) in acute phase. Finally, we observed that blood parasitism during early period of infection seems to be more related to DTU than to a specific strain.

Entities:  

Mesh:

Year:  2015        PMID: 26204180     DOI: 10.1515/ap-2015-0060

Source DB:  PubMed          Journal:  Acta Parasitol        ISSN: 1230-2821            Impact factor:   1.440


  9 in total

1.  Co-infection with distinct Trypanosoma cruzi strains induces an activated immune response in human monocytes.

Authors:  Luísa M D Magalhães; Lívia S A Passos; Egler Chiari; Lúcia M C Galvão; Carolina C Koh; Marina L Rodrigues-Alves; Rodolfo C Giunchetti; Kenneth Gollob; Walderez O Dutra
Journal:  Parasite Immunol       Date:  2019-09-30       Impact factor: 2.280

2.  Molecular Diagnosis of Chagas Disease in Colombia: Parasitic Loads and Discrete Typing Units in Patients from Acute and Chronic Phases.

Authors:  Carolina Hernández; Zulma Cucunubá; Carolina Flórez; Mario Olivera; Carlos Valencia; Pilar Zambrano; Cielo León; Juan David Ramírez
Journal:  PLoS Negl Trop Dis       Date:  2016-09-20

3.  A multi-parametric analysis of Trypanosoma cruzi infection: common pathophysiologic patterns beyond extreme heterogeneity of host responses.

Authors:  Julien Santi-Rocca; Fernando Fernandez-Cortes; Carlos Chillón-Marinas; María-Luisa González-Rubio; David Martin; Núria Gironès; Manuel Fresno
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

4.  Epidemiological modeling of Trypanosoma cruzi: Low stercorarian transmission and failure of host adaptive immunity explain the frequency of mixed infections in humans.

Authors:  Nicolás Tomasini; Paula Gabriela Ragone; Sébastien Gourbière; Juan Pablo Aparicio; Patricio Diosque
Journal:  PLoS Comput Biol       Date:  2017-05-08       Impact factor: 4.475

5.  Performance of TcI/TcVI/TcII Chagas-Flow ATE-IgG2a for universal and genotype-specific serodiagnosis of Trypanosoma cruzi infection.

Authors:  Glaucia Diniz Alessio; Fernanda Fortes de Araújo; Denise Fonseca Côrtes; Policarpo Ademar Sales Júnior; Daniela Cristina Lima; Matheus de Souza Gomes; Laurence Rodrigues do Amaral; Marcelo Antônio Pascoal Xavier; Andréa Teixeira-Carvalho; Olindo Assis Martins-Filho; Marta de Lana
Journal:  PLoS Negl Trop Dis       Date:  2017-03-23

6.  Trypanosoma cruzi Detection in Colombian Patients with a Diagnosis of Esophageal Achalasia.

Authors:  Santiago Panesso-Gómez; Paula Pavia; Iván Enrique Rodríguez-Mantilla; Paola Lasso; Luis A Orozco; Adriana Cuellar; Concepción J Puerta; Belén Mendoza de Molano; John M González
Journal:  Am J Trop Med Hyg       Date:  2018-02-01       Impact factor: 2.345

7.  Disease Tolerance and Pathogen Resistance Genes May Underlie Trypanosoma cruzi Persistence and Differential Progression to Chagas Disease Cardiomyopathy.

Authors:  Christophe Chevillard; João Paulo Silva Nunes; Amanda Farage Frade; Rafael Ribeiro Almeida; Ramendra Pati Pandey; Marilda Savóia Nascimento; Jorge Kalil; Edecio Cunha-Neto
Journal:  Front Immunol       Date:  2018-12-03       Impact factor: 7.561

8.  Mixed infections by different Trypanosoma cruzi discrete typing units among Chagas disease patients in an endemic community in Panama.

Authors:  Alexa Prescilla Ledezma; Roberto Blandon; Alejandro G Schijman; Alejandro Benatar; Azael Saldaña; Antonio Osuna
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

Review 9.  Precision Health for Chagas Disease: Integrating Parasite and Host Factors to Predict Outcome of Infection and Response to Therapy.

Authors:  Santiago J Martinez; Patricia S Romano; David M Engman
Journal:  Front Cell Infect Microbiol       Date:  2020-05-08       Impact factor: 6.073

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.